Skip to main content

Table 2 Treatment patterns and resource utilisation in the treatment and post-treatment follow-up of cervical cancer (percentages are average values based on experts’ responses)

From: Cost-effectiveness of human papillomavirus vaccination in Germany

Cervical cancer stage (FIGO classification) or treatment phase Treatment patterns and resource utilisation
FIGO IA1 Conisation 60%
Conisation with pelvic lymph node dissection 10%
Simple hysterectomy 20%
Simple hysterectomy with pelvic lymph node dissection 10%
FIGO IA2 Conisation with pelvic lymph node dissection 20%
Radical trachelectomy with pelvic lymph node dissection 10%
Simple hysterectomy 10%
Simple hysterectomy with pelvic lymph node dissection 60%
FIGO IB1 Radical hysterectomy with pelvic lymph node dissection 64%
Radical hysterectomy with pelvic lymph node dissection and adjuvant chemoradiotherapy 16%
Radical trachelectomy with pelvic lymph node dissection 5%
Chemoradiotherapy 15%
FIGO IB2 Radical hysterectomy with pelvic and paraaortic lymph node dissection 49%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 21%
Chemoradiotherapy 30%
FIGO IIA Radical hysterectomy with pelvic and paraaortic lymph node dissection 35%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 15%
Chemoradiotherapy 50%
FIGO IIB Radical hysterectomy with pelvic and paraaortic lymph node dissection 12%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 18%
Chemoradiotherapy 70%
FIGO IIIA Radical hysterectomy with pelvic and paraaortic lymph node dissection 2%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 8%
Chemoradiotherapy 90%
FIGO IIIB Radical hysterectomy with pelvic and paraaortic lymph node dissection 2%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 8%
Chemoradiotherapy 90%
FIGO IVA Radical hysterectomy with pelvic and paraaortic lymph node dissection 2%
Radical hysterectomy with pelvic and paraaortic lymph node dissection and adjuvant chemoradiotherapy 8%
Chemoradiotherapy 80%
Exenteration 2%
Exenteration and adjuvant chemoradiotherapy 8%
FIGO IVB Chemoradiotherapy 40%
Palliative chemotherapy 60%
Post-treatment follow-up Outpatient visits, Pap-smears, and pelvic and abdominal ultrasonography 100%
Hormone replacement therapy (women <50 years) 50%
Manual lymphatic drainage and medical compression tights 10–30%
  1. FIGO International Federation of Gynecology and Obstetrics